Related Experiment Videos
Idiopathic intracranial hypertension (pseudotumor cerebri) in pediatric patients
R S Baker1, R J Baumann, J R Buncic
1Department of Ophthalmology, University of Kentucky, Lexington.
Insights
Idiopathic intracranial hypertension in children can cause reversible optic neuropathy. Further research is needed to determine the best medical and surgical treatments for this condition.
Area of Science:
- Ophthalmology
- Neurology
- Pediatrics
Background:
- Idiopathic intracranial hypertension (IIH) in pediatric patients presents diagnostic challenges.
- Visual feature evaluation has improved, revealing potential optic neuropathy.
- Optic neuropathy in pediatric IIH may be reversible with timely intervention.
Purpose of the Study:
- To highlight the significance of visual feature evaluation in pediatric IIH.
- To emphasize the potential reversibility of optic neuropathy associated with pediatric IIH.
- To advocate for comprehensive etiological investigations and optimized management strategies.
Main Methods:
- Review of current diagnostic approaches for visual features in pediatric IIH.
- Analysis of reported cases demonstrating optic neuropathy in pediatric IIH.
- Discussion of therapeutic strategies, including nonspecific methods for intracranial pressure reduction.
Main Results:
- Improved evaluation techniques have identified optic neuropathy in pediatric IIH patients.
- The identified optic neuropathy shows potential for reversibility.
- Etiologic associations require thorough investigation for definitive therapy.
Conclusions:
- Early and accurate evaluation of visual features is crucial in pediatric IIH.
- Prompt management, including pressure reduction, may reverse optic neuropathy.
- Further clinical trials are essential to establish optimal medical and surgical treatments for pediatric IIH.
Abstract:
Improved evaluation of visual features of idiopathic intracranial hypertension in pediatric patients has resulted in the demonstration of optic neuropathy which may be reversible. A wide variety of etiologic associations should be investigated to provide definitive therapy; however, nonspecific means often will be required to lower intracranial pressure. It is hoped that a double-blind controlled trial of medical therapies and another for surgical therapies will be conducted to elucidate optimum management of this condition.